U.S. PHARMACOPEIA

Search USP29  
Dipivefrin Hydrochloride
Click to View Image
C19H29NO5·HCl 387.90

Propanoic acid, 2,2-dimethyl-, 4-[1-hydroxy-2-(methylamino)ethyl]-1,2-phenylene ester, hydrochloride, (±)-.
(±)-3,4-Dihydroxy--[(methylamino)methyl]benzyl alcohol 3,4-dipivalate hydrochloride [64019-93-8].
» Dipivefrin Hydrochloride contains not less than 98.5 percent and not more than 101.5 percent of C19H29NO5·HCl, calculated on the dried basis.
Packaging and storage— Preserve in tight containers.
Identification—
B: The retention time of the major peak in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation, as obtained in the Assay.
C: A solution (1 in 100) meets the requirements of the tests for Chloride 191.
Melting range 741: between 155 and 165, but the range between beginning and end of melting does not exceed 2.
Loss on drying 731 Dry it in a suitable vacuum drying tube over phosphorus pentoxide at 60 for 6 hours: it loses not more than 1.0% of its weight.
Residue on ignition 281: not more than 0.3%.
Heavy metals, Method I 231: not more than 0.0015%.
Iron 241: not more than 5 ppm.
Standard iron solution— Use the Standard Iron Solution prepared as directed under Iron 241.
Hydroxylamine solution— Dissolve 5 g of hydroxylamine hydrochloride in 50 mL of water.
Triazine solution— Dissolve 125 mg of 2,4,6-tri-(2-pyridyl)-S-triazine in 100 mL of methanol.
Standard solution— Into a 50-mL color-comparison tube pipet 1 mL of Standard iron solution, add 42.0 mL of water, and mix.
Test solution— Into a 50-mL color-comparison tube add 2.0 g of Dipivefrin Hydrochloride, 43.0 mL of water, and mix.
Procedure— To each of the tubes containing the Standard solution and the Test solution, add 5.0 mL of Hydroxylamine solution, 2.0 mL of Triazine solution, and mix: the color of the solution from the Test solution is not darker than that of the solution from the Standard solution.
Residual solvents 467: meets the requirements.
(Official January 1, 2007)
Assay—
Mobile phase— Prepare a mixture of acetonitrile, 0.014 M sodium dodecyl sulfate, and glacial acetic acid (24:15:1).
Standard preparation— Dissolve a suitable quantity of USP Dipivefrin Hydrochloride RS, accurately weighed, in 0.0015 N hydrochloric acid to obtain a solution having a known concentration of about 5 mg per mL.
Assay preparation— Prepare as directed for Standard preparation, using 500 mg of Dipivefrin Hydrochloride, accurately weighed, in place of the Reference Standard.
Chromatographic system (see Chromatography 621) The liquid chromatograph is equipped with a 254-nm detector and a 4-mm × 30-cm column that contains packing L1. The flow rate is about 2 mL per minute. Chromatograph the Standard preparation, and record the peak responses as directed for Procedure: the column efficiency is not less than 500 theoretical plates; the tailing factor for the major peak is not more than 1.5; and the relative standard deviation for replicate injections is not more than 2.0%.
Procedure— Separately inject equal volumes (about 20 µL) of the Standard preparation and the Assay preparation into the chromatograph by means of a suitable microsyringe or sampling valve, record the chromatograms, and measure the responses for the major peaks. Calculate the quantity, in mg, of C19H29NO5·HCl in the portion of Dipivefrin Hydrochloride taken by the formula:
100C(rU / rS),
in which C is the concentration, in mg per mL, of USP Dipivefrin Hydrochloride RS in the Standard preparation; and rU and rS are the peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information— Staff Liaison : Feiwen Mao, M.S., Senior Scientific Associate
Expert Committee : (MDOOD05) Monograph Development-Ophthalmics Oncologics and Dermatologicals
USP29–NF24 Page 734
Pharmacopeial Forum : Volume No. 28(4) Page 1105
Phone Number : 1-301-816-8320